Vivos Therapeutics, Inc. · NASDAQ:VVOS
Armistice Capital, LLC's stake in Vivos Therapeutics, Inc. fell to 4.99% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Armistice Capital, LLC's stake in Vivos Therapeutics, Inc. fell to 4.99%, 729,755 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 729,755
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 729,755 |
| Steven Boyd | 4.99% | 729,755 |
Source
Related
- Vivos Therapeutics, Inc.
- Armistice Capital, LLC
- Vivos Therapeutics, Inc. shareholders
- Schedule 13G · Armistice Capital, LLC · May 15, 2026
- Form 4 · Huntsman Ronald Kirk · Sep 18, 2026
- Schedule 13G/A · Streeterville Capital LLC · Sep 3, 2026
- Form 4 · Amman Bradford K. · Aug 26, 2026
- Schedule 13G · Streeterville Capital LLC · Aug 11, 2026
- Schedule 13D · V-Co Investors 4 LLC · Jul 15, 2026